by adminAdrianRamirez | Jan 9, 2017 | Axim Biotechnologies, Press Releases
AXIM Biotechnologies Announces Positive Pharmacokinetic (PK) Data Results on Proprietary Delivery Method for Cannabinoids in Chewing Gum SAN DIEGO, CA — (Marketwired) — 01/09/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded...
by adminAdrianRamirez | Jan 6, 2017 | Axim Biotechnologies, Press Releases
SAN DIEGO, CA — (Marketwired) — 01/06/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first publicly traded cannabis company in the United States, today announced that the Company was featured in a recent High Times article, “10 Largest...
by adminAdrianRamirez | Jan 5, 2017 | HempMeds Brasil, Press Releases
Partnership to Provide Expanded Accessibility to RSHO(TM), the First-Ever Product Approved for Import by Brazilian Government SAN DIEGO, CA — (Marketwired) — 01/05/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded cannabis...
by adminAdrianRamirez | Jan 4, 2017 | Axim Biotechnologies, Press Releases
NEW YORK – Jan. 04, 2017 – AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, and gears up for clinical trial on alleviating...
by adminAdrianRamirez | Dec 29, 2016 | HempMeds Brasil, HempMeds Mexico, Press Releases
Article Features Unique Nature of Export Agreement of Cannabis-Related Products From Southern California to Latin America SAN DIEGO, CA — (Marketwired) — 12/29/16 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded cannabis...
by adminAdrianRamirez | Dec 28, 2016 | HempMeds, Media Coverage, Press Releases
Medical Marijuana, Inc. subsidiary HempMeds® prominently discussed in nation’s most widely read alternative weekly newspaper. The expansion of HempMeds® into Latin America received coverage in LA Weekly late last week when the weekly paper ran a story on Mexico’s...
